BIOKRYPTIS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 388,798 | 372,075 | 420,135 | 365,504 | 332,723 | 392,916 | 453,444 | 452,280 |
| Profit before tax | 62,769 | 34,830 | 55,645 | 43,867 | - | - | - | - |
| Net profit | 53,311 | 29,579 | 47,298 | 37,580 | 2,374 | 37,842 | 62,062 | 69,404 |
| Equity | 124,340 | 124,919 | 172,217 | 149,797 | 152,170 | 190,013 | 182,074 | 181,514 |
| Liabilities | 32,710 | 23,529 | 31,157 | 62,228 | 45,356 | 49,080 | 36,172 | 27,873 |
| Non-current assets | 17,144 | 11,363 | 7,115 | 55,285 | 43,091 | 41,224 | 50,472 | 38,948 |
| Current assets | 139,265 | 136,536 | 195,911 | 155,789 | 153,730 | 197,224 | 166,270 | 169,646 |
| Total assets | 156,409 | 147,899 | 203,026 | 211,074 | 196,821 | 238,448 | 216,742 | 208,594 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 72,389 | 113,184 | 120,649 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.3% | -4.3% | +12.9% | -13.0% | -9.0% | +18.1% | +15.4% | -0.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 34.1% | 20.0% | 23.3% | 17.8% | 1.2% | 15.9% | 28.6% | 33.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 42.9% | 23.7% | 27.5% | 25.1% | 1.6% | 19.9% | 34.1% | 38.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.7% | 7.9% | 11.3% | 10.3% | 0.7% | 9.6% | 13.7% | 15.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 16.1% | 9.4% | 13.2% | 12.0% | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.2 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 76,485 | 81,181 | 102,891 | 91,376 | 92,854 | 130,972 | 151,148 | 150,760 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOKRYPTIS - Social security debts
The company had no debts to Sodra
BIOKRYPTIS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-03 | 2025-05-05 | 111.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOKRYPTIS, UAB (code 125824176) is a Private Limited Liability Company engaged in the wholesale of other machinery and equipment. In 2025, the company generated revenue of €452.3K and net profit of €69.4K, with a profit margin of 15.3%. Revenue was broadly stable compared with 2024, when it reached €453.4K, after rising from €392.9K in 2023. Profitability improved steadily over the three-year period, with net profit increasing from €37.8K in 2023 to €62.1K in 2024 and €69.4K in 2025. The balance sheet remained solid in 2025, with total assets of €208.6K, equity of €181.5K and liabilities of €27.9K. The equity ratio stood at 87.0%, while debt-to-equity was 0.15, indicating a low leverage position. Asset turnover was 2.17x, reflecting efficient use of assets. Productivity was also strong, with revenue per employee of €150.8K and profit per employee of €23.1K. Overall, the latest 2025 results show stable sales and improving earnings despite a slight decline in revenue from the prior year.